UK Startup Resurrect Bio Raises €8.8 Million To Develop Disease-Resistant Crops

It previously secured over €6.8 million ($8 million) in an initial close in February 2026 bringing its total Series A funding to a strong conclusion.

The round was led by Corteva via its Corteva Catalyst platform, with participation from Calculus Capital, Pymwymic, UKI2S (managed by Future Planet Capital), SynBioVen and AgFunder. Including earlier seed funding in 2023 Resurrect Bio’s total funding now stands at approximately $12.4 million since its founding.

Spun out of The Sainsbury Laboratory in Norwich, the company was founded in 2022 by Professor Sophien Kamoun, Professor Tolga Bozkurt, and Dr Cian Duggan. Its mission is to become a global leader in plant disease resistance by developing novel traits in-house and partnering with seed companies to improve crop protection.

Read Also - Twin Prime Raises $10M To Build Frontier AI For Defence And Security

Resurrect Bio aims to provide a more sustainable option than chemical pesticides by improving how plants naturally fight diseases. It works by turning back on hidden resistance genes that already exist in crops, helping plants strengthen their own built-in defenses against pathogens.

The new funding will support scaling three core platforms: FloraFold®, an AI-driven in silico discovery system for predicting plant–pathogen protein interactions; a high-throughput functional biology platform for validating those predictions; and its Resurrection platform, which reactivates hidden resistance traits in elite crop germplasm.

The company is working more closely with seed companies and plant breeders through joint projects to bring stronger disease resistance traits into farming faster. In March 2026, it also announced a partnership with Corteva Agriscience to develop corn varieties that are resistant to disease.

Dr Cian Duggan, CEO of Resurrect Bio. “The strength of this raise reflects growing conviction in what we’re building: a scalable, AI-driven platform for resurrecting disease resistance in the world’s most important crops. It’s also a validation of what’s possible when you combine the UK’s world-class plant science base with commercial ambition to translate it into real-world impact.

“We’re expanding our team, deepening our platforms and actively seeking joint development agreements with seed companies and breeders who want to bring durable resistance traits to farmers.”

About Resurrect Bio

Resurrect Bio, founded in 2022 is a plant biotech startup supported by investors. It helps crops fight diseases by using gene editing to bring back their natural resistance. The company improves plant immunity by reactivating useful genes making crops stronger against pests and diseases without adding any new foreign DNA.